Eye Allergy Treatment Market
The Eye Allergy Treatment Market Size is anticipated to reach USD 2,926.92 Million by 2030 at 4.90% CAGR during the forecast period 2022-2030.
Eye allergies affect a huge number of individuals each year also, are portrayed by an overcompensation of the immune system to an allergen through eating, touching or breathing it into the lungs. Eye allergies are one of the most common health problems across the globe. Approximately 50 million people have some or the other kind of eye allergy in US alone. Eye allergy are regularly joined by nasal allergy symptoms, for example, wheezing and sneezing, however can likewise happen alone. Allergens are found inside and outside. Grass, tree and wood dusts are the most widely recognized open air allergens, while the most basic indoor allergens incorporate pet hair (dander), clean bugs and molds.
The eye allergy treatment market is expected to grow at a steady pace. The factors influencing the growth of the market include rising prevalence of numerous eye allergies are major driver for the market while some other factors like growing awareness, technological advancements, new therapies, and growing healthcare expenditure are also major driving influencing the global eye allergy treatment market.
Eye Allergy Treatment Market Insights And Share Analysis By Type (Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Contact Allergic Conjunctivitis), Treatment (Medications Allergy Shots), And End User (Hospitals Clinics)-Forecast Till 2030.
Major Key Players:
ALLERGAN (Republic of Ireland), Johnson Johnson Vision Care, Inc. (US), Merck Co., Inc. (US), Novartis AG (Switzerland), Pfizer Inc. (US), Regeneron Pharmaceuticals, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Santen Pharmaceutical Co., Ltd.(Japan), Valeant (Canada) Shire (Republic of Ireland), are some of the prominent players at the forefront of competition in the global Eye Allergy Treatment Market Players.
Segment Analysis
The global eye allergy treatment market has been segmented on the basis of type, treatment, and end-users. Based on type, the eye allergy treatment market is segmented into seasonal and perennial allergic conjunctivitis, atopic keratoconjunctivitis, vernal keratoconjunctivitis, contact allergic conjunctivitis, giant papillary conjunctivitis, and others. The vernal keratoconjunctivitis segment includes palpebral, limbal, corneal, and others.
Based on treatment, the global eye allergy market is segmented into medication, allergy shots (immunotherapy), and others. Medication includes artificial tears, decongestants, oral antihistamines, antihistamine/mast-cell stabilizers, corticosteroids. The decongestants segment is sub-segmented into with antihistamines and without antihistamines. The sub-segments of allergy shots (immunotherapy) segment include subcutaneous immunotherapy treatment (SCIT) and sublingual immunotherapy treatment (SLIT).
Based on end-users, the global eye allergy market is segmented into eye hospitals and clinics, medical institutes, research centers, and others.
Regional Analysis
The global eye allergy treatment market has been geographically segmented into four major regions such as Americas, Europe, Asia Pacific, and the Middle East and Africa. Among these regions, Americas account for the largest market share in the global eye allergy treatment market due to the high investment for research and development by the pharmaceutical companies in this region and well-formed regulatory framework for the launch of new drugs and medication in the market.
The eye allergy treatment market in the Europe region is driven by the increased healthcare expenditure, well-developed healthcare infrastructure, and increased incidences of eye allergy in this region. Whereas, the Asia Pacific region is projecting the fastest growth of the eye allergy treatment market owing to the increasing awareness among the individuals, the rapid development of healthcare sector, and increasing adoption of advanced technology in the production line.
The eye allergy treatment market in the Middle East and Africa is projecting slower growth as compared to the other regions in the global eye allergy treatment market due to the negligence and lack of awareness regarding eye allergies in the underdeveloped countries of this region.
About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans conducts meet with the industry experts and industrial visits for its research analyst members.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
